Late-infantile Neuronal Ceroid Lipofuscinosis Type
📧 Sign up to get email alerts when something new happens for Late-infantile Neuronal Ceroid Lipofuscinosis Type.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-03-27FDA Approved: BRINEURA — Supplemental Application (BioMarin Pharmaceutical Inc.)
FDA approves a supplemental application for Brineura (cerliponase alfa) from BioMarin Pharmaceutical Inc.